These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 37174632)

  • 1. Progerinin, an Inhibitor of Progerin, Alleviates Cardiac Abnormalities in a Model Mouse of Hutchinson-Gilford Progeria Syndrome.
    Kang SM; Seo S; Song EJ; Kweon O; Jo AH; Park S; Woo TG; Kim BH; Oh GT; Park BJ
    Cells; 2023 Apr; 12(9):. PubMed ID: 37174632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vascular Smooth Muscle-Specific Progerin Expression Accelerates Atherosclerosis and Death in a Mouse Model of Hutchinson-Gilford Progeria Syndrome.
    Hamczyk MR; Villa-Bellosta R; Gonzalo P; Andrés-Manzano MJ; Nogales P; Bentzon JF; López-Otín C; Andrés V
    Circulation; 2018 Jul; 138(3):266-282. PubMed ID: 29490993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of mitochondrial dysfunction in Hutchinson-Gilford progeria syndrome through use of stable isotope labeling with amino acids in cell culture.
    Rivera-Torres J; Acín-Perez R; Cabezas-Sánchez P; Osorio FG; Gonzalez-Gómez C; Megias D; Cámara C; López-Otín C; Enríquez JA; Luque-García JL; Andrés V
    J Proteomics; 2013 Oct; 91():466-77. PubMed ID: 23969228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progerinin, an optimized progerin-lamin A binding inhibitor, ameliorates premature senescence phenotypes of Hutchinson-Gilford progeria syndrome.
    Kang SM; Yoon MH; Ahn J; Kim JE; Kim SY; Kang SY; Joo J; Park S; Cho JH; Woo TG; Oh AY; Chung KJ; An SY; Hwang TS; Lee SY; Kim JS; Ha NC; Song GY; Park BJ
    Commun Biol; 2021 Jan; 4(1):5. PubMed ID: 33398110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Defective extracellular pyrophosphate metabolism promotes vascular calcification in a mouse model of Hutchinson-Gilford progeria syndrome that is ameliorated on pyrophosphate treatment.
    Villa-Bellosta R; Rivera-Torres J; Osorio FG; Acín-Pérez R; Enriquez JA; López-Otín C; Andrés V
    Circulation; 2013 Jun; 127(24):2442-51. PubMed ID: 23690466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cellular stress and AMPK activation as a common mechanism of action linking the effects of metformin and diverse compounds that alleviate accelerated aging defects in Hutchinson-Gilford progeria syndrome.
    Finley J
    Med Hypotheses; 2018 Sep; 118():151-162. PubMed ID: 30037605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paclitaxel mitigates structural alterations and cardiac conduction system defects in a mouse model of Hutchinson-Gilford progeria syndrome.
    Macías Á; Díaz-Larrosa JJ; Blanco Y; Fanjul V; González-Gómez C; Gonzalo P; Andrés-Manzano MJ; da Rocha AM; Ponce-Balbuena D; Allan A; Filgueiras-Rama D; Jalife J; Andrés V
    Cardiovasc Res; 2022 Jan; 118(2):503-516. PubMed ID: 33624748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascular smooth muscle cell-specific progerin expression in a mouse model of Hutchinson-Gilford progeria syndrome promotes arterial stiffness: Therapeutic effect of dietary nitrite.
    Del Campo L; Sánchez-López A; Salaices M; von Kleeck RA; Expósito E; González-Gómez C; Cussó L; Guzmán-Martínez G; Ruiz-Cabello J; Desco M; Assoian RK; Briones AM; Andrés V
    Aging Cell; 2019 Jun; 18(3):e12936. PubMed ID: 30884114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ghrelin delays premature aging in Hutchinson-Gilford progeria syndrome.
    Ferreira-Marques M; Carvalho A; Franco AC; Leal A; Botelho M; Carmo-Silva S; Águas R; Cortes L; Lucas V; Real AC; López-Otín C; Nissan X; de Almeida LP; Cavadas C; Aveleira CA
    Aging Cell; 2023 Dec; 22(12):e13983. PubMed ID: 37858983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hutchinson-Gilford Progeria Syndrome: A premature aging disease caused by LMNA gene mutations.
    Gonzalo S; Kreienkamp R; Askjaer P
    Ageing Res Rev; 2017 Jan; 33():18-29. PubMed ID: 27374873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interruption of progerin-lamin A/C binding ameliorates Hutchinson-Gilford progeria syndrome phenotype.
    Lee SJ; Jung YS; Yoon MH; Kang SM; Oh AY; Lee JH; Jun SY; Woo TG; Chun HY; Kim SK; Chung KJ; Lee HY; Lee K; Jin G; Na MK; Ha NC; Bárcena C; Freije JM; López-Otín C; Song GY; Park BJ
    J Clin Invest; 2016 Oct; 126(10):3879-3893. PubMed ID: 27617860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metformin decreases progerin expression and alleviates pathological defects of Hutchinson-Gilford progeria syndrome cells.
    Egesipe AL; Blondel S; Lo Cicero A; Jaskowiak AL; Navarro C; Sandre-Giovannoli A; Levy N; Peschanski M; Nissan X
    NPJ Aging Mech Dis; 2016; 2():16026. PubMed ID: 28721276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unique progerin C-terminal peptide ameliorates Hutchinson-Gilford progeria syndrome phenotype by rescuing BUBR1.
    Zhang N; Hu Q; Sui T; Fu L; Zhang X; Wang Y; Zhu X; Huang B; Lu J; Li Z; Zhang Y
    Nat Aging; 2023 Feb; 3(2):185-201. PubMed ID: 37118121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular Progerin Suppression and Lamin A Restoration Rescue Hutchinson-Gilford Progeria Syndrome.
    Sánchez-López A; Espinós-Estévez C; González-Gómez C; Gonzalo P; Andrés-Manzano MJ; Fanjul V; Riquelme-Borja R; Hamczyk MR; Macías Á; Del Campo L; Camafeita E; Vázquez J; Barkaway A; Rolas L; Nourshargh S; Dorado B; Benedicto I; Andrés V
    Circulation; 2021 Nov; 144(22):1777-1794. PubMed ID: 34694158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Premature Vascular Aging with Features of Plaque Vulnerability in an Atheroprone Mouse Model of Hutchinson-Gilford Progeria Syndrome with
    Nevado RM; Hamczyk MR; Gonzalo P; Andrés-Manzano MJ; Andrés V
    Cells; 2020 Oct; 9(10):. PubMed ID: 33049978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hutchinson-Gilford Progeria Syndrome (Hgps) and Application of Gene Therapy Based Crispr/Cas Technology as A Promising Innovative Treatment Approach.
    Rajeev M; Ratan C; Krishnan K; Vijayan M
    Recent Pat Biotechnol; 2021; 15(4):266-285. PubMed ID: 34602042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impaired end joining induces cardiac atrophy in a Hutchinson-Gilford progeria mouse model.
    Chen Y; Huang S; Cui Z; Sun X; Tang Y; Zhang H; Chen Z; Jiang R; Zhang W; Li X; Chen J; Liu B; Jiang Y; Wei K; Mao Z
    Proc Natl Acad Sci U S A; 2023 Nov; 120(47):e2309200120. PubMed ID: 37967221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A conserved splicing mechanism of the LMNA gene controls premature aging.
    Lopez-Mejia IC; Vautrot V; De Toledo M; Behm-Ansmant I; Bourgeois CF; Navarro CL; Osorio FG; Freije JM; Stévenin J; De Sandre-Giovannoli A; Lopez-Otin C; Lévy N; Branlant C; Tazi J
    Hum Mol Genet; 2011 Dec; 20(23):4540-55. PubMed ID: 21875900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emerging candidate treatment strategies for Hutchinson-Gilford progeria syndrome.
    Strandgren C; Revêchon G; Sola-Carvajal A; Eriksson M
    Biochem Soc Trans; 2017 Dec; 45(6):1279-1293. PubMed ID: 29127216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vascular Smooth Muscle Cell-Specific Progerin Expression Provokes Contractile Impairment in a Mouse Model of Hutchinson-Gilford Progeria Syndrome that Is Ameliorated by Nitrite Treatment.
    Del Campo L; Sánchez-López A; González-Gómez C; Andrés-Manzano MJ; Dorado B; Andrés V
    Cells; 2020 Mar; 9(3):. PubMed ID: 32182706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.